ATG5 as a Serum Marker of Autophagy in Psoriatic Patient

• Conditions: Psoriasis Vulgaris; Autophagy
• Interventions: Diagnostic Test: serum ATG5

• Registration Number: NCT05279638
• Lead Sponsor: Sohag University

Brief Summary

it will be of interest to know the ATG 5 as a serum marker of autophagy in serum of psoriasis vulgairs patients and explore its relationship with psoriasis severity.

Detailed Description

Not available

Study Timeline

• Study Start: 2022-02-01
• Study First Submitted: 2022-02-23
• Status Verified: 2022-03
• Study First Submitted QC: 2022-03-06
• Last Update Submitted: 2022-03-06
• Study First Posted: 2022-03-15
• Last Update Posted: 2022-03-15
• Primary Completion: 2023-02-01
• Study Completion: 2024-01-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Psoriasis vulgaris of both sex, age 18-55 years

Exclusion Criteria

i. Patients with other types of psoriasis ii. Pregnant or lactating women iii. patients with hepatic or renal diseases iv. patients receive any systemic treatment in last 3 months

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
healthy participants	serum ATG5	-
psoriasis vulgaris patients	serum ATG5	psoriasis vulgaris patients , both sex , 18,55 years old

Primary Outcome Measures

Name	Time	Method
serum level of ATG5 in psoriatic patients	Within 6 months	evaluation of serum ATG5 in psoriasis vulgaris patients by ELISA

Trial Locations

Locations (1)

Sohag University; 🇪🇬 Sohag, Egypt